Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-21
2007-08-21
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S262000, C544S362000
Reexamination Certificate
active
10778441
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 7057039 (2006-06-01), Bernotas et al.
patent: 2002/0165251 (2002-11-01), Caldirola et al.
patent: 2003/0073700 (2003-04-01), Beard et al.
patent: 2004/0023970 (2004-02-01), Bernotas et al.
patent: 2005/0085481 (2005-04-01), Bernotas et al.
patent: 2006/0142330 (2006-06-01), Bernotas et al.
Wojciechowski, et al., Synthesis, 1986, vol. 8, pp. 651-653.
Bernotas Ronald Charles
Yan Yinfa
Grazier Nyeemah
Lences Barbara L.
Wyeth
LandOfFree
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3851687